Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma Surgery”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07286903
What this trial is testing

Fluorescence Enhanced Stereotactic Surgery (FESS)

Who this might be right for
High Grade GliomaHigh Grade Glioma (III or IV)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 20
Testing effectiveness (Phase 2)UnknownNCT00009854
What this trial is testing

Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Direct Therapeutics
Early research (Phase 1)Study completedNCT02234297
What this trial is testing

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Who this might be right for
Glioma
Blaze Bioscience Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University
Testing effectiveness (Phase 2)Study completedNCT02014844
What this trial is testing

Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma

Who this might be right for
Glioblastoma
ImmunityBio, Inc. 28
Not applicableLooking for participantsNCT06915649
What this trial is testing

Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

Who this might be right for
Hippocampal SclerosisDysembryoplastic Neuroepithelial TumorCortical Dysplasia+6 more
University Hospital, Montpellier 3,504
Testing effectiveness (Phase 2)Looking for participantsNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Testing effectiveness (Phase 2)Study completedNCT01128218
What this trial is testing

The Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors

Who this might be right for
Brain Neoplasms
Southern Illinois University 33
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Testing effectiveness (Phase 2)Looking for participantsNCT02394626
What this trial is testing

Surgery for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Insel Gruppe AG, University Hospital Bern 120
Testing effectiveness (Phase 2)Ended earlyNCT03018288
What this trial is testing

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
National Cancer Institute (NCI) 90
Not applicableUnknownNCT03641391
What this trial is testing

Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction

Who this might be right for
Glioma
Huashan Hospital 300
Testing effectiveness (Phase 2)UnknownNCT02681705
What this trial is testing

Radiation Therapy and Combination Chemotherapy for Medulloblastoma

Who this might be right for
Medulloblastoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Early research (Phase 1)Study completedNCT00003410
What this trial is testing

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00075491
What this trial is testing

Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00890032
What this trial is testing

Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Central Nervous System Neoplasm
John Sampson 50
Early research (Phase 1)Study completedNCT02105233
What this trial is testing

Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid

Who this might be right for
Brain NeoplasmsGlioma
St. Olavs Hospital 15
Not applicableWithdrawnNCT00645385
What this trial is testing

Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma
Weill Medical College of Cornell University
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Next Page